Weil Gotshal & Manges advised CeNeS Pharmaceuticals on a development licence agreement with Hertfordshire-based Bioglan Pharma to work on the production of an aerosol inhaler version of a drug to combat pain in post-operative and cancer patients. James Gubbins, pharmaceutical and biotechnology partner at Weil Gotshal & Manges, led the team that represented CeNeS. Norton Rose and Roiter Zucker acted for Bioglan Pharma.